Take 36 well meaning questions from many people who care about pharmaceuticals, disclosure, safety, and social media and send them to the FDA, and read “we are unable to comment” as the answer for almost each one.

http://www.fdasm.com/docs/FINAL%20DDMAC%20Responses%20to%20FDASM_Questions.pdf

Unsatisfying.